Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Sarcoma × perifosine × Clear all

Phase

Status

Sponsor Class

NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Congenital Abnormalities 1

Interventions

Doxorubicin 17 Cyclophosphamide 17 Radiotherapy 13 Vincristine 11 Magnetic Resonance Spectroscopy 11 Ifosfamide 11 Specimen Handling 10 Biopsy 9 Filgrastim 8 Etoposide 8 Dactinomycin 7 X-Rays 6 Temozolomide 6 Sirolimus 6 Phantoms, Imaging 6 Melphalan 6 temsirolimus 5 cixutumumab 5 Thalidomide 4 Sorafenib 4 Nuclear Medicine Department, Hospital 4 Ipilimumab 4 Fluorodeoxyglucose F18 4 Celecoxib 4 pazopanib 3 ixabepilone 3 Topotecan 3 Semaxinib 3 Radiation 3 Peripheral Blood Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00064324 2013-06-04

Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡